This page lists all known medications that could potentially lead to 'Myocardial reinfarction' as a side effect. It's important to note that mild side effects are quite common with medications. The ...

Death or reinfarction is delayed by more than one year with a primary percutaneous coronary intervention (PCI) strategy that includes hospital transfer, compared to fibrinolysis, according to late ...

Contrary to some recent reports indicating a full 12 months of dual antiplatelet therapy following percutaneous coronary intervention (PCI) is unnecessary, a large Danish registry study shows that ...

Please provide your email address to receive an email when new articles are posted on . In a meta-analysis of trials of patients with STEMI and multivessel CAD who underwent PCI, those who had ...

"...these are important results that may improve the outcomes of STEMI patients, especially those who do not undergo primary PCI as a reperfusion strategy." OASIS-6 ...

A 75 year old, non-diabetic and normotensive man presented with a history of chest pain with duration of 5 days. He had a history of breathlessness of NYHA Class IV with orthopnea. EKG showed QS in V1 ...

Madrid, Spain – 30 August 2025: Beta-blocker therapy showed no evidence of an effect on all-cause death, reinfarction or heart failure admission in patients with myocardial infarction (MI) managed ...

Auckland, New Zealand - Bivalirudin (Angiomax? - The Medicines Company) should be considered as a new anticoagulant treatment option in patients with acute MI (AMI) treated with streptokinase, ...

Beta-adrenergic blocking drugs were thefirst agents shown in large clinical trials toimprove the outcomes of survivors of acutemyocardial infarction (MI). Lower mortalitywas observed in the group ...

Patients with ST-segment elevation myocardial infarction (STEMI) benefit from treatment with aspirin and thrombolytic therapy; however, the conflicting findings of studies examining the effect of ...